Trial Outcomes & Findings for Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial (NCT NCT02295644)

NCT ID: NCT02295644

Last Updated: 2018-06-07

Results Overview

Pain intensity measurement scale from 0 to 10, 0 is no pain, 10 is the worst pain ever

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

28 participants

Primary outcome timeframe

Immediately before and after the intervention, difference used.

Results posted on

2018-06-07

Participant Flow

Participant milestones

Participant milestones
Measure
A (0.4W/Square Centimeter, 50%)
0.4 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
B (0.4W/Square Centimeter, 100%)
0.4 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
C (0.8W/Square Centimeter, 50%)
0.8 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
D (0.8W/Square Centimeter, 100%)
0.8 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
Overall Study
STARTED
7
7
7
7
Overall Study
COMPLETED
7
7
6
5
Overall Study
NOT COMPLETED
0
0
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
A (0.4W/Square Centimeter, 50%)
0.4 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
B (0.4W/Square Centimeter, 100%)
0.4 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
C (0.8W/Square Centimeter, 50%)
0.8 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
D (0.8W/Square Centimeter, 100%)
0.8 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
Overall Study
Did not meet inclusion criterion
0
0
1
2

Baseline Characteristics

Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
A(0.4W/Square Centimeter, 50%)
n=7 Participants
0.4 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
B(0.4W/Square Centimeter, 100%)
n=7 Participants
0.4 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
C (0.8W/Square Centimeter, 50%)
n=6 Participants
0.8 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
D (0.8W/Square Centimeter, 100%)
n=5 Participants
0.8 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
Total
n=25 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Age, Categorical
Between 18 and 65 years
7 Participants
n=5 Participants
7 Participants
n=7 Participants
6 Participants
n=5 Participants
5 Participants
n=4 Participants
25 Participants
n=21 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
7 Participants
n=7 Participants
6 Participants
n=5 Participants
5 Participants
n=4 Participants
25 Participants
n=21 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Region of Enrollment
United States
7 participants
n=5 Participants
7 participants
n=7 Participants
6 participants
n=5 Participants
5 participants
n=4 Participants
25 participants
n=21 Participants

PRIMARY outcome

Timeframe: Immediately before and after the intervention, difference used.

Pain intensity measurement scale from 0 to 10, 0 is no pain, 10 is the worst pain ever

Outcome measures

Outcome measures
Measure
A (0.4W/Square Centimeter, 50%)
n=7 Participants
0.4 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
B (0.4W/Square Centimeter, 100%)
n=7 Participants
0.4 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
C (0.8W/Square Centimeter, 50%)
n=6 Participants
0.8 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
D (0.8W/Square Centimeter, 100%)
n=5 Participants
0.8 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
Self Report of Pain
-.86 Scores on pain intensity scale
Standard Deviation 1.4
-2.0 Scores on pain intensity scale
Standard Deviation .87
-1.4 Scores on pain intensity scale
Standard Deviation 1.1
-1.3 Scores on pain intensity scale
Standard Deviation 1.4

PRIMARY outcome

Timeframe: Immediately before and after the intervention, difference used.

Measuring pressure pain threshold using digital algometer

Outcome measures

Outcome measures
Measure
A (0.4W/Square Centimeter, 50%)
n=7 Participants
0.4 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
B (0.4W/Square Centimeter, 100%)
n=7 Participants
0.4 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
C (0.8W/Square Centimeter, 50%)
n=6 Participants
0.8 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
D (0.8W/Square Centimeter, 100%)
n=5 Participants
0.8 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
Pressure Pain Threshold of the Masseter Muscle
-2.64 Kpa/Cm^2
Standard Deviation 31.79
15.21 Kpa/Cm^2
Standard Deviation 5.75
-5.12 Kpa/Cm^2
Standard Deviation 9.44
-10.2 Kpa/Cm^2
Standard Deviation 12.04

PRIMARY outcome

Timeframe: Immediately before and after the intervention, difference used.

Using digital thermometer on buccal mucosa, degrees celsius.

Outcome measures

Outcome measures
Measure
A (0.4W/Square Centimeter, 50%)
n=7 Participants
0.4 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
B (0.4W/Square Centimeter, 100%)
n=7 Participants
0.4 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
C (0.8W/Square Centimeter, 50%)
n=6 Participants
0.8 Watts/Sq cm 50% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
D (0.8W/Square Centimeter, 100%)
n=5 Participants
0.8 Watts/Sq cm 100% Duty cycle Ultrasound Sonicator 740: Therapeutic ultrasound (Ultrasound Sonicator 740) used on masseter muscle, 1MHz, 5 minutes
Intraoral Muscle Temperature
.036 degrees Celsius, post minus pre
Standard Deviation .09
.15 degrees Celsius, post minus pre
Standard Deviation .206
.033 degrees Celsius, post minus pre
Standard Deviation .154
.42 degrees Celsius, post minus pre
Standard Deviation .40

Adverse Events

A(0.4W/Square Centimeter, 50%)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

B(0.4W/Square Centimeter, 100%)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

C(0.8W/Square Centimeter, 50%)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

D (0.8W/Square Centimeter, 100%)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Willard D McCall

University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences

Phone: (716)829-3559

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place